Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Experimental Hematology|September 19, 2012
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphomaKejie Zhang, Michael Wang, Archito T Tamayo, et al.
Leukemia & Lymphoma|March 12, 2014
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed diseaseLan V Pham, Muychi T Vang, Archito T Tamayo, et al.
Blood|February 22, 2007
Development of a murine model for blastoid variant mantle-cell lymphomaRichard J Ford, Long Shen, Yen Chiu Lin-Lee, et al.
Blood|September 14, 2018
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphomaLi Li, Jun Zhang, Juan Chen, et al.
Oncotarget|October 8, 2016
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphomaLan V Pham, Jerry L Bryant, Richard Mendez, et al.
Oncotarget|October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, Manasi Das, et al.
The Journal of Biological Chemistry|March 11, 2005
Assembly of the kappa preB receptor requires a V kappa-like protein encoded by a germline transcriptRoberto Rangel, Morgan R McKeller, Jennifer C Sims-Mourtada, et al.
Oncotarget|February 9, 2018
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphomaWei Liu, Juan Chen, Archito T Tamayo, et al.
Biochemical Pharmacology|June 13, 2012
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphomaMi-Ae Lyu, Lan V Pham, Bokyung Sung, et al.
Blood|December 12, 2018
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, An Phan, et al.
Pageof 5